Compass Wealth Management LLC Acquires 17,090 Shares of Agilent Technologies, Inc. $A

Key Points

• Compass Wealth Management acquired 17,090 Agilent Technologies shares in the third quarter, valued at approximately $2.95 million. Several other institutional investors also increased or initiated positions.
• Agilent reported stronger-than-expected quarterly results, with EPS of $1.62 versus the $1.49 consensus and revenue of $1.88 billion, up 8.1% year over year. The company guided to fiscal 2026 EPS of $6.18–$6.21.
• Analyst sentiment remains favorable, with a consensus rating of “Moderate Buy” and an average price target of $173.65. Agilent also declared a quarterly dividend of $0.255 per share, representing a 0.6% yield.

Compass Wealth Management LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 17,090 shares of the medical research company's stock, valued at approximately $2,945,000.

Other large investors also recently modified their holdings of the company. Root Financial Partners LLC increased its stake in Agilent Technologies by 47.3% in the 3rd quarter. Root Financial Partners LLC now owns 2,429 shares of the medical research company's stock worth $419,000 after buying an additional 780 shares in the last quarter. Lmcg Investments LLC raised its holdings in Agilent Technologies by 6.2% during the third quarter. Lmcg Investments LLC now owns 105,340 shares of the medical research company's stock valued at $18,151,000 after acquiring an additional 6,117 shares during the period. Cardinal Capital Management lifted its position in shares of Agilent Technologies by 3.8% in the third quarter. Cardinal Capital Management now owns 78,054 shares of the medical research company's stock valued at $13,449,000 after acquiring an additional 2,854 shares in the last quarter. Axxcess Wealth Management LLC purchased a new position in shares of Agilent Technologies in the third quarter valued at about $894,000. Finally, Albion Financial Group UT lifted its position in shares of Agilent Technologies by 1.7% in the third quarter. Albion Financial Group UT now owns 10,328 shares of the medical research company's stock valued at $1,780,000 after acquiring an additional 168 shares in the last quarter.

Agilent Technologies Stock Down 2.1%

A opened at $174.03 on Friday. The firm has a 50-day simple moving average of $160.99 and a two-hundred day simple moving average of $139.38. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $179.10. The company has a market capitalization of $49.07 billion, a PE ratio of 29.33, a price-to-earnings-growth ratio of 2.71 and a beta of 1.21. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same quarter last year, the business posted $1.37 earnings per share. The business's quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be issued a dividend of $0.2550 per share. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, October 6th. Agilent Technologies's dividend payout ratio (DPR) is currently 20.08%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on A. Royal Bank Of Canada upped their price objective on Agilent Technologies from $155.00 to $185.00 and gave the stock an "outperform" rating in a research note on Thursday, August 27th. Weiss Ratings raised Agilent Technologies from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, October 8th. Jefferies Financial Group began coverage on Agilent Technologies in a research note on Thursday, July 9th. They issued a "hold" rating and a $135.00 price target for the company. Stifel Nicolaus increased their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a "buy" rating in a report on Thursday, August 27th. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $180.00 to $196.00 and gave the company a "buy" rating in a report on Tuesday, October 13th. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $173.65.

Insiders Place Their Bets

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares of the company's stock, valued at $745,395.12. The trade was a 11.41% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.